0 XP   0   0   0

Merck & Company Inc










Financial Health of Merck & Company Inc




Comparing to competitors in the Other industry




  Industry Rankings  


Merck & Company Inc
Buy, Hold or Sell?

Should you buy, hold or sell Merck & Company Inc?

I guess you are interested in Merck & Company Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Merck & Company Inc

Let's start. I'm going to help you getting a better view of Merck & Company Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Merck & Company Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Merck & Company Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Merck & Company Inc. The closing price on 2022-12-02 was €176.85 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Merck & Company Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Merck & Company Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Merck & Company Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • A Net Profit Margin of 15.6% means that €0.16 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Merck & Company Inc:

  • The MRQ is 15.6%. The company is making a huge profit. +2
  • The TTM is 15.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.6%TTM15.8%-0.2%
TTM15.8%YOY14.8%+1.0%
TTM15.8%5Y12.3%+3.5%
5Y12.3%10Y12.3%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ15.6%8.2%+7.4%
TTM15.8%7.4%+8.4%
YOY14.8%7.3%+7.5%
5Y12.3%6.7%+5.6%
10Y12.3%6.6%+5.7%
1.1.2. Return on Assets

Shows how efficient Merck & Company Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • 1.8% Return on Assets means that Merck & Company Inc generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Merck & Company Inc:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY1.6%+0.2%
TTM1.8%5Y1.3%+0.5%
5Y1.3%10Y1.3%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%1.0%+0.8%
TTM1.8%1.0%+0.8%
YOY1.6%0.9%+0.7%
5Y1.3%0.9%+0.4%
10Y1.3%0.9%+0.4%
1.1.3. Return on Equity

Shows how efficient Merck & Company Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • 3.3% Return on Equity means Merck & Company Inc generated €0.03 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Merck & Company Inc:

  • The MRQ is 3.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM3.7%-0.3%
TTM3.7%YOY3.7%-0.1%
TTM3.7%5Y2.9%+0.7%
5Y2.9%10Y2.9%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3%3.1%+0.2%
TTM3.7%2.9%+0.8%
YOY3.7%2.6%+1.1%
5Y2.9%2.4%+0.5%
10Y2.9%2.4%+0.5%

1.2. Operating Efficiency of Merck & Company Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Merck & Company Inc is operating .

  • Measures how much profit Merck & Company Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Merck & Company Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY15.2%-15.2%
TTM-5Y15.5%-15.5%
5Y15.5%10Y15.5%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY15.2%9.2%+6.0%
5Y15.5%8.5%+7.0%
10Y15.5%8.5%+7.0%
1.2.2. Operating Ratio

Measures how efficient Merck & Company Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are €1.17 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Merck & Company Inc:

  • The MRQ is 1.166. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.165. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.166TTM1.165+0.001
TTM1.165YOY1.192-0.028
TTM1.1655Y1.213-0.048
5Y1.21310Y1.2130.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1661.218-0.052
TTM1.1651.189-0.024
YOY1.1921.203-0.011
5Y1.2131.289-0.076
10Y1.2131.314-0.101

1.3. Liquidity of Merck & Company Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Merck & Company Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.28 means the company has €1.28 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Merck & Company Inc:

  • The MRQ is 1.278. The company is just able to pay all its short-term debts.
  • The TTM is 1.117. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.278TTM1.117+0.160
TTM1.117YOY1.024+0.094
TTM1.1175Y1.048+0.069
5Y1.04810Y1.0480.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2781.491-0.213
TTM1.1171.465-0.348
YOY1.0241.475-0.451
5Y1.0481.299-0.251
10Y1.0481.286-0.238
1.3.2. Quick Ratio

Measures if Merck & Company Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • A Quick Ratio of 0.47 means the company can pay off €0.47 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Merck & Company Inc:

  • The MRQ is 0.468. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.410. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.468TTM0.410+0.057
TTM0.410YOY0.376+0.034
TTM0.4105Y0.372+0.039
5Y0.37210Y0.3720.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4680.612-0.144
TTM0.4100.602-0.192
YOY0.3760.600-0.224
5Y0.3720.563-0.191
10Y0.3720.552-0.180

1.4. Solvency of Merck & Company Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Merck & Company Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Merck & Company Inc to Other industry mean.
  • A Debt to Asset Ratio of 0.47 means that Merck & Company Inc assets are financed with 46.6% credit (debt) and the remaining percentage (100% - 46.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Merck & Company Inc:

  • The MRQ is 0.466. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.506. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.466TTM0.506-0.040
TTM0.506YOY0.574-0.068
TTM0.5065Y0.554-0.048
5Y0.55410Y0.5540.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4660.562-0.096
TTM0.5060.583-0.077
YOY0.5740.586-0.012
5Y0.5540.583-0.029
10Y0.5540.576-0.022
1.4.2. Debt to Equity Ratio

Measures if Merck & Company Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • A Debt to Equity ratio of 87.4% means that company has €0.87 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Merck & Company Inc:

  • The MRQ is 0.874. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.034. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.874TTM1.034-0.159
TTM1.034YOY1.355-0.321
TTM1.0345Y1.258-0.224
5Y1.25810Y1.2580.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8741.244-0.370
TTM1.0341.337-0.303
YOY1.3551.370-0.015
5Y1.2581.439-0.181
10Y1.2581.455-0.197

2. Market Valuation of Merck & Company Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Merck & Company Inc generates.

  • Above 15 is considered overpriced but always compare Merck & Company Inc to the Other industry mean.
  • A PE ratio of 80.46 means the investor is paying €80.46 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Merck & Company Inc:

  • The EOD is 88.686. Neutral. Compare to industry.
  • The MRQ is 80.461. Neutral. Compare to industry.
  • The TTM is 101.215. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD88.686MRQ80.461+8.224
MRQ80.461TTM101.215-20.754
TTM101.215YOY96.293+4.922
TTM101.2155Y84.170+17.045
5Y84.17010Y84.1700.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD88.68636.308+52.378
MRQ80.46138.458+42.003
TTM101.21544.588+56.627
YOY96.29348.072+48.221
5Y84.17040.090+44.080
10Y84.17041.443+42.727
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Merck & Company Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Merck & Company Inc:

  • The MRQ is -5,366.162. Very Bad. -2
  • The TTM is 801.585. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-5,366.162TTM801.585-6,167.747
TTM801.585YOY-8,738.209+9,539.794
TTM801.5855Y-2,870.824+3,672.409
5Y-2,870.82410Y-2,870.8240.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,366.1620.154-5,366.316
TTM801.5850.050+801.535
YOY-8,738.2090.186-8,738.395
5Y-2,870.8240.158-2,870.982
10Y-2,870.8240.155-2,870.979

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Merck & Company Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 2.68 means the investor is paying €2.68 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Merck & Company Inc:

  • The EOD is 2.954. Good. +1
  • The MRQ is 2.680. Good. +1
  • The TTM is 3.709. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD2.954MRQ2.680+0.274
MRQ2.680TTM3.709-1.029
TTM3.709YOY3.382+0.327
TTM3.7095Y2.543+1.166
5Y2.54310Y2.5430.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD2.9541.411+1.543
MRQ2.6801.419+1.261
TTM3.7091.575+2.134
YOY3.3821.352+2.030
5Y2.5431.288+1.255
10Y2.5431.330+1.213
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Merck & Company Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.9903.834+82%0.768+811%5.442+28%5.442+28%
Book Value Growth--0.0700.022+225%-0.036+152%-0.024+134%-0.024+134%
Book Value Per Share--59.86752.391+14%42.180+42%35.980+66%35.980+66%
Book Value Per Share Growth--0.1170.071+65%0.016+631%0.123-5%0.123-5%
Current Ratio--1.2781.117+14%1.024+25%1.048+22%1.048+22%
Debt To Asset Ratio--0.4660.506-8%0.574-19%0.554-16%0.554-16%
Debt To Equity Ratio--0.8741.034-15%1.355-35%1.258-30%1.258-30%
Dividend Per Share--1.9900.550+262%0.104+1812%0.382+421%0.382+421%
Dividend Per Share Growth--0.8950.947-6%1.000-11%-19.667+2298%-19.667+2298%
Eps--1.9941.903+5%1.571+27%1.168+71%1.168+71%
Eps Growth---0.0150.036-141%0.052-129%0.098-115%0.098-115%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.1560.158-1%0.148+6%0.123+27%0.123+27%
Operating Margin----0%0.152-100%0.155-100%0.155-100%
Operating Ratio--1.1661.165+0%1.192-2%1.213-4%1.213-4%
Pb Ratio2.954+9%2.6803.709-28%3.382-21%2.543+5%2.543+5%
Pe Ratio88.686+9%80.461101.215-21%96.293-16%84.170-4%84.170-4%
Peg Ratio---5366.162801.585-769%-8738.209+63%-2870.824-47%-2870.824-47%
Price Per Share176.850+9%160.450191.375-16%142.738+12%138.247+16%138.247+16%
Price To Total Gains Ratio19.695+9%17.86965.964-73%-412.921+2411%-130.678+831%-130.678+831%
Profit Growth---6.889-1.472-79%0.142-4965%-3.447-50%-3.447-50%
Quick Ratio--0.4680.410+14%0.376+24%0.372+26%0.372+26%
Return On Assets--0.0180.018-1%0.016+12%0.013+35%0.013+35%
Return On Equity--0.0330.037-9%0.037-10%0.029+14%0.029+14%
Revenue Growth--0.017-0.019+211%-0.010+161%-0.022+232%-0.022+232%
Total Gains Per Share--8.9794.384+105%0.872+930%5.824+54%5.824+54%
Total Gains Per Share Growth--0.5740.230+150%2.527-77%-1.731+402%-1.731+402%
Usd Book Value--27411139900.00023988038350.000+14%19312800900.000+42%20493326000.000+34%20493326000.000+34%
Usd Book Value Change Per Share--7.3614.038+82%0.808+811%5.731+28%5.731+28%
Usd Book Value Per Share--63.04655.173+14%44.420+42%37.891+66%37.891+66%
Usd Dividend Per Share--2.0950.579+262%0.110+1812%0.402+421%0.402+421%
Usd Eps--2.1002.004+5%1.655+27%1.230+71%1.230+71%
Usd Price Per Share186.241+9%168.970201.537-16%150.317+12%145.588+16%145.588+16%
Usd Profit--913037700.000871440250.000+5%719530575.000+27%610045785.714+50%610045785.714+50%
Usd Revenue--5863660800.0005516137800.000+6%4882698150.000+20%4824627207.143+22%4824627207.143+22%
Usd Total Gains Per Share--9.4564.617+105%0.918+930%6.134+54%6.134+54%
 EOD+2 -3MRQTTM+25 -9YOY+27 -85Y+29 -610Y+29 -6

3.2. Fundamental Score

Let's check the fundamental score of Merck & Company Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1588.686
Price to Book Ratio (EOD)Between0-12.954
Net Profit Margin (MRQ)Greater than00.156
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.468
Current Ratio (MRQ)Greater than11.278
Debt to Asset Ratio (MRQ)Less than10.466
Debt to Equity Ratio (MRQ)Less than10.874
Return on Equity (MRQ)Greater than0.150.033
Return on Assets (MRQ)Greater than0.050.018
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Merck & Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.083
Ma 20Greater thanMa 50174.530
Ma 50Greater thanMa 100169.047
Ma 100Greater thanMa 200172.564
OpenGreater thanClose175.700
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets48,717,000
Total Liabilities22,688,000
Total Stockholder Equity25,955,000
 As reported
Total Liabilities 22,688,000
Total Stockholder Equity+ 25,955,000
Total Assets = 48,717,000

Assets

Total Assets48,717,000
Total Current Assets12,416,000
Long-term Assets12,416,000
Total Current Assets
Cash And Cash Equivalents 1,580,000
Short-term Investments 133,000
Net Receivables 4,414,000
Inventory 4,474,000
Other Current Assets 1,362,000
Total Current Assets  (as reported)12,416,000
Total Current Assets  (calculated)11,963,000
+/- 453,000
Long-term Assets
Goodwill 18,573,000
Intangible Assets 7,862,000
Long-term Assets Other 99,000
Long-term Assets  (as reported)36,301,000
Long-term Assets  (calculated)26,534,000
+/- 9,767,000

Liabilities & Shareholders' Equity

Total Current Liabilities9,718,000
Long-term Liabilities12,970,000
Total Stockholder Equity25,955,000
Total Current Liabilities
Accounts payable 2,456,000
Other Current Liabilities 2,297,000
Total Current Liabilities  (as reported)9,718,000
Total Current Liabilities  (calculated)4,753,000
+/- 4,965,000
Long-term Liabilities
Long-term Liabilities Other 16,000
Long-term Liabilities  (as reported)12,970,000
Long-term Liabilities  (calculated)16,000
+/- 12,954,000
Total Stockholder Equity
Retained Earnings 18,015,000
Total Stockholder Equity (as reported)25,955,000
Total Stockholder Equity (calculated)18,015,000
+/- 7,940,000
Other
Capital Stock565,000
Common Stock Shares Outstanding 434,778
Net Invested Capital 25,955,000
Net Working Capital 2,698,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
38,717,000
39,568,000
42,067,000
43,811,000
44,743,000
43,822,000
43,231,000
41,796,000
43,891,000
43,145,000
43,836,000
45,362,000
46,235,000
48,717,000
48,717,00046,235,00045,362,00043,836,00043,145,00043,891,00041,796,00043,231,00043,822,00044,743,00043,811,00042,067,00039,568,00038,717,000
   > Total Current Assets 
10,512,000
11,694,000
13,518,000
9,003,000
10,013,000
9,726,000
10,258,000
9,280,000
10,617,000
10,182,000
10,315,000
10,982,000
11,085,000
12,416,000
12,416,00011,085,00010,982,00010,315,00010,182,00010,617,0009,280,00010,258,0009,726,00010,013,0009,003,00013,518,00011,694,00010,512,000
       Cash And Cash Equivalents 
2,340,000
3,451,000
5,111,000
541,000
1,530,000
1,512,000
1,548,000
1,110,000
2,238,000
1,825,000
1,523,000
1,511,000
1,339,000
1,580,000
1,580,0001,339,0001,511,0001,523,0001,825,0002,238,0001,110,0001,548,0001,512,0001,530,000541,0005,111,0003,451,0002,340,000
       Short-term Investments 
64,000
154,000
275,000
29,000
81,000
32,000
85,000
29,000
691,000
45,000
142,000
112,000
106,000
133,000
133,000106,000112,000142,00045,000691,00029,00085,00032,00081,00029,000275,000154,00064,000
       Net Receivables 
3,616,000
3,468,000
3,440,000
3,488,000
3,690,000
3,509,000
3,487,000
3,221,000
3,654,000
3,657,000
3,753,000
3,646,000
4,138,000
4,414,000
4,414,0004,138,0003,646,0003,753,0003,657,0003,654,0003,221,0003,487,0003,509,0003,690,0003,488,0003,440,0003,468,0003,616,000
       Inventory 
2,937,000
3,033,000
3,135,000
3,342,000
3,443,000
3,537,000
3,428,000
3,294,000
3,462,000
3,564,000
3,760,000
3,900,000
4,143,000
4,474,000
4,474,0004,143,0003,900,0003,760,0003,564,0003,462,0003,294,0003,428,0003,537,0003,443,0003,342,0003,135,0003,033,0002,937,000
       Other Current Assets 
1,126,000
1,284,000
1,232,000
97,000
553,000
585,000
1,099,000
76,000
0
624,000
683,000
94,000
792,000
1,362,000
1,362,000792,00094,000683,000624,000076,0001,099,000585,000553,00097,0001,232,0001,284,0001,126,000
   > Long-term Assets 
28,204,000
27,874,000
28,550,000
34,808,000
34,730,000
34,096,000
32,973,000
32,516,000
33,273,000
32,963,000
33,521,000
34,380,000
35,149,000
36,301,000
36,301,00035,149,00034,380,00033,521,00032,963,00033,273,00032,516,00032,973,00034,096,00034,730,00034,808,00028,550,00027,874,00028,204,000
       Goodwill 
13,966,000
13,841,000
14,309,000
17,141,000
17,376,000
17,118,000
16,512,000
15,959,000
16,541,000
16,347,000
16,670,000
17,004,000
17,761,000
18,573,000
18,573,00017,761,00017,004,00016,670,00016,347,00016,541,00015,959,00016,512,00017,118,00017,376,00017,141,00014,309,00013,841,00013,966,000
       Intangible Assets 
7,052,000
6,770,000
6,730,000
9,175,000
9,089,000
8,664,000
8,172,000
7,653,000
7,765,000
7,613,000
7,628,000
7,612,000
7,549,000
7,862,000
7,862,0007,549,0007,612,0007,628,0007,613,0007,765,0007,653,0008,172,0008,664,0009,089,0009,175,0006,730,0006,770,0007,052,000
       Long-term Assets Other 
81,000
87,000
91,000
80,000
94,000
91,000
91,000
62,000
84,000
87,000
84,000
74,000
104,000
99,000
99,000104,00074,00084,00087,00084,00062,00091,00091,00094,00080,00091,00087,00081,000
> Total Liabilities 
21,042,000
21,994,000
23,885,000
25,898,000
26,143,000
25,796,000
25,236,000
24,779,000
24,908,000
23,784,000
23,157,000
23,946,000
23,245,000
22,688,000
22,688,00023,245,00023,946,00023,157,00023,784,00024,908,00024,779,00025,236,00025,796,00026,143,00025,898,00023,885,00021,994,00021,042,000
   > Total Current Liabilities 
11,194,000
10,494,000
9,655,000
11,842,000
10,764,000
10,080,000
9,709,000
9,231,000
10,652,000
9,820,000
9,793,000
10,432,000
10,207,000
9,718,000
9,718,00010,207,00010,432,0009,793,0009,820,00010,652,0009,231,0009,709,00010,080,00010,764,00011,842,0009,655,00010,494,00011,194,000
       Short-term Debt 
0
0
0
4,423,000
0
0
0
0
0
0
0
0
0
0
00000000004,423,000000
       Short Long Term Debt 
0
0
0
4,423,000
0
0
0
2,182,000
0
0
0
2,379,000
0
0
002,379,0000002,182,0000004,423,000000
       Accounts payable 
1,633,000
1,737,000
1,736,000
2,054,000
1,807,000
1,764,000
1,684,000
1,768,000
1,937,000
2,107,000
2,132,000
1,542,000
2,356,000
2,456,000
2,456,0002,356,0001,542,0002,132,0002,107,0001,937,0001,768,0001,684,0001,764,0001,807,0002,054,0001,736,0001,737,0001,633,000
       Other Current Liabilities 
1,863,000
1,629,000
1,688,000
564,000
1,852,000
1,718,000
1,983,000
666,000
2,277,000
2,052,000
2,239,000
839,000
2,417,000
2,297,000
2,297,0002,417,000839,0002,239,0002,052,0002,277,000666,0001,983,0001,718,0001,852,000564,0001,688,0001,629,0001,863,000
   > Long-term Liabilities 
9,848,000
11,500,000
14,230,000
14,056,000
15,379,000
15,716,000
15,527,000
15,548,000
14,256,000
13,964,000
13,364,000
13,514,000
13,038,000
12,970,000
12,970,00013,038,00013,514,00013,364,00013,964,00014,256,00015,548,00015,527,00015,716,00015,379,00014,056,00014,230,00011,500,0009,848,000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-3,856,000
0
0
0
439,000
0
0
0
459,000
0
0
00459,000000439,000000-3,856,000000
       Long-term Liabilities Other 
227,000
226,000
225,000
2,000
91,000
88,000
111,000
-1,000
40,000
30,000
15,000
0
15,000
16,000
16,00015,000015,00030,00040,000-1,000111,00088,00091,0002,000225,000226,000227,000
> Total Stockholder Equity
17,640,000
17,550,000
18,158,000
17,865,000
18,556,000
17,982,000
17,928,000
16,946,000
18,916,000
19,293,000
20,607,000
21,338,000
22,919,000
25,955,000
25,955,00022,919,00021,338,00020,607,00019,293,00018,916,00016,946,00017,928,00017,982,00018,556,00017,865,00018,158,00017,550,00017,640,000
   Common Stock00000000000000
   Retained Earnings 
11,294,000
11,410,000
11,314,000
11,507,000
11,978,000
11,753,000
12,581,000
12,378,000
13,511,000
14,134,000
14,955,000
15,134,000
16,450,000
18,015,000
18,015,00016,450,00015,134,00014,955,00014,134,00013,511,00012,378,00012,581,00011,753,00011,978,00011,507,00011,314,00011,410,00011,294,000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue19,687,000
Cost of Revenue-7,351,000
Gross Profit12,336,00012,336,000
 
Operating Income (+$)
Gross Profit12,336,000
Operating Expense-15,491,000
Operating Income4,196,000-3,155,000
 
Operating Expense (+$)
Research Development2,408,000
Selling General Administrative4,955,000
Selling And Marketing Expenses-
Operating Expense15,491,0007,363,000
 
Net Interest Income (+$)
Interest Income46,000
Interest Expense-272,000
Net Interest Income-226,000-226,000
 
Pretax Income (+$)
Operating Income4,196,000
Net Interest Income-226,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)3,924,0004,196,000
EBIT - interestExpense = -272,000
3,055,000
3,327,000
Interest Expense272,000
Earnings Before Interest and Taxes (ebit)-4,196,000
Earnings Before Interest and Taxes (ebitda)5,958,000
 
After tax Income (+$)
Income Before Tax3,924,000
Tax Provision-859,000
Net Income From Continuing Ops3,065,0003,065,000
Net Income3,055,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-226,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DISHTV.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DISHTV.BSE.

DISHTV.BSE Daily Candlestick Chart
DFM.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DFM.BSE.

DFM.BSE Daily Candlestick Chart
CHANDNI.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHANDNI.BSE.

CHANDNI.BSE Daily Candlestick Chart
CEATLTD.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CEATLTD.BSE.

CEATLTD.BSE Daily Candlestick Chart
AXISBANK.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AXISBANK.BSE.

AXISBANK.BSE Daily Candlestick Chart
ASHOKA.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASHOKA.BSE.

ASHOKA.BSE Daily Candlestick Chart
ALFAVIO.BSE
22 hours ago

I found you a Death Cross on the daily chart of ALFAVIO.BSE.

ALFAVIO.BSE Daily Candlestick Chart
AJMERA.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AJMERA.BSE.

AJMERA.BSE Daily Candlestick Chart
HCM.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HCM.LSE.

HCM.LSE Daily Candlestick Chart
DOCS.LSE
22 hours ago

I found you a Death Cross on the daily chart of DOCS.LSE.

DOCS.LSE Daily Candlestick Chart
RMAP.LSE
22 hours ago

I found you a Death Cross on the daily chart of RMAP.LSE.

RMAP.LSE Daily Candlestick Chart
CPH2.LSE
22 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of CPH2.LSE.

CPH2.LSE Daily Candlestick Chart
ABF.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ABF.LSE.

ABF.LSE Daily Candlestick Chart
DOM.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DOM.LSE.

DOM.LSE Daily Candlestick Chart
DNLM.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DNLM.LSE.

DNLM.LSE Daily Candlestick Chart
FCRM.LSE
22 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FCRM.LSE.

FCRM.LSE Daily Candlestick Chart
XLPS.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XLPS.LSE.

XLPS.LSE Daily Candlestick Chart
PHGP.LSE
22 hours ago

I found you a Death Cross on the daily chart of PHGP.LSE.

PHGP.LSE Daily Candlestick Chart
EMLI.LSE
22 hours ago

I found you a Golden Cross on the daily chart of EMLI.LSE.

EMLI.LSE Daily Candlestick Chart
SLVR.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SLVR.LSE.

SLVR.LSE Daily Candlestick Chart
GBAL.TO
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GBAL.TO.

GBAL.TO Daily Candlestick Chart
ACC.BSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ACC.BSE.

ACC.BSE Daily Candlestick Chart
VRL.BSE
23 hours ago

I found you a Golden Cross on the daily chart of VRL.BSE.

VRL.BSE Daily Candlestick Chart
CANDOUR.BSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CANDOUR.BSE.

CANDOUR.BSE Daily Candlestick Chart